Pretreatment Hemoglobin as an Independent Prognostic Factor in Primary Central Nervous System Lymphomas.

Le M, Garcilazo Y, Ibáñez-Juliá MJ, Younan N, Royer-Perron L, Benazra M, Mokhtari K, Houillier C, Hoang-Xuan K, Alentorn A

Open source

DOI
10.1634/theoncologist.2018-0629
Published
2019 Sep
Container
The oncologist
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1634/theoncologist.2018-0629,
  title = {Pretreatment Hemoglobin as an Independent Prognostic Factor in Primary Central Nervous System Lymphomas.},
  author = {Le M and Garcilazo Y and Ibáñez-Juliá MJ and Younan N and Royer-Perron L and Benazra M and Mokhtari K and Houillier C and Hoang-Xuan K and Alentorn A},
  year = {2019},
  journal = {The oncologist},
  doi = {10.1634/theoncologist.2018-0629},
  url = {https://doi.org/10.1634/theoncologist.2018-0629}
}

RIS

TY  - JOUR
TI  - Pretreatment Hemoglobin as an Independent Prognostic Factor in Primary Central Nervous System Lymphomas.
AU  - Le M
AU  - Garcilazo Y
AU  - Ibáñez-Juliá MJ
AU  - Younan N
AU  - Royer-Perron L
AU  - Benazra M
AU  - Mokhtari K
AU  - Houillier C
AU  - Hoang-Xuan K
AU  - Alentorn A
PY  - 2019
JO  - The oncologist
DO  - 10.1634/theoncologist.2018-0629
UR  - https://doi.org/10.1634/theoncologist.2018-0629
ER  - 

APA

M, L., Y, G., MJ, I., N, Y., L, R., M, B., K, M., C, H., K, H., & A, A. (2019). Pretreatment Hemoglobin as an Independent Prognostic Factor in Primary Central Nervous System Lymphomas.. The oncologist. https://doi.org/10.1634/theoncologist.2018-0629

Source records